{"id":4649,"date":"2016-06-21T08:08:32","date_gmt":"2016-06-21T08:08:32","guid":{"rendered":"https:\/\/jurmed.ro\/pacienti\/?p=4649"},"modified":"2016-06-21T08:09:06","modified_gmt":"2016-06-21T08:09:06","slug":"cmho","status":"publish","type":"post","link":"https:\/\/jurmed.ro\/pacienti\/cmho\/","title":{"rendered":"Cardiomiopatia hipertrofic\u0103 una dintre principalele cauze de deces subit la sportivii de performan\u021b\u0103"},"content":{"rendered":"<div style=\"text-align: justify\"><\/div>\n<div style=\"text-align: justify\">\n<p><strong><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/gallery.mailchimp.com\/f77d55688330df2da57a83c26\/images\/755dd3ce-4c6c-4d9e-b300-e3de6171b304.jpg\" width=\"150\" height=\"209\" align=\"left\" \/>Cardiomiopatia hipertrofic\u0103 a fost cauza unic\u0103 cea mai frecvent\u0103 de moarte subit\u0103, ap\u0103r\u00e2nd la 36% din atle\u021bii care au avut o boal\u0103 cardiac\u0103 confirmat\u0103 prin autopsie.<\/strong> <strong>Aceste date apar \u00een \u201dRegistrul Na\u021bional al Mor\u021bii Subite la Atle\u021bi\u201d din Statele Unite ale Americii, publicat \u00een 2016, care a studiat 2.406 mor\u021bi subite, \u00eenregistrate \u00eentre anii 1980-2011, la tinerii atle\u021bi cu v\u00e2rste \u00eentre 19\u00b16 ani. Din cele 2.406 de cazuri de moarte subit\u0103, doar 842 au avut drept cauz\u0103 de deces o boal\u0103 cardiovascular\u0103 confirmat\u0103 prin autopsie, restul prezent\u00e2nd alte cauze ale mor\u021bii.<\/strong><\/p>\n<p><strong>Cauze<\/strong><\/p>\n<p>Cardiomiopatia hipertrofic\u0103 (CMH) este o afec\u0163iune cardiac\u0103 primar\u0103 determinat\u0103, de cele mai multe ori, de factori genetici, caracterizat\u0103 prin \u020bngro\u015farea pere\u0163ilor ventriculari \u0219i dezorganizarea arhitecturii mu\u015fchiului inimii. &#8222;Este cel mai frecvent tip de cardiomiopatie, prevalen\u0163a acesteia fiind de 0,2% \u00een popula\u0163ia general\u0103. Din punct de vedere clinic, simptomatologia variaz\u0103 larg, de la asimptomatic p\u00e2n\u0103 la cazuri invalidante cu insuficien\u0163\u0103 cardiac\u0103 sever\u0103 sau moarte subit\u0103. CMHO este una dintre principalele cauze de deces subit la pacien\u021bii tineri, mai ales la sportivii de performan\u021b\u0103&#8221;, explic\u0103 Dr. Lucian Doroban\u0163u (foto), coordonatorul Cardiomyopathy Center din Spitalul Monza.<\/p>\n<p><strong>Diagnostic si tratament<\/strong><\/p>\n<p>Cardiomiopatia hipertrofic\u0103 obstructiv\u0103 este foarte dificil de diagnosticat \u0219i tratat \u0219i implic\u0103 controale am\u0103nun\u021bite \u0219i tratament de specialitate, iar din acest motiv se \u00eenregistreaz\u0103 un procent foarte mare de mor\u021bi subite provocate de CMHO la tinerii atle\u021bi. Conform ghidurilor europene \u0219i americane de tratament al CMHO, acesta trebuie s\u0103 se desf\u0103\u0219oare \u00een centre consacrate, cu speciali\u0219ti dedica\u021bi \u0219i servicii integrate care s\u0103 aib\u0103 experien\u021b\u0103 \u00een aceast\u0103 patologie.<br \/>\nDiagnosticul pacien\u021bilor cu CMHO presupune efectuarea urm\u0103toarelor investiga\u021bii: electrocardiogram\u0103, ecocardiografie transtoracic\u0103 de repaus \u0219i de stres, ecocardiografie transesofagian\u0103, Holter ECG\/48 de ore, rezonan\u0163\u0103 magnetic\u0103 cardiac\u0103 (esen\u0163ial\u0103 inclusiv \u00een managementul intraoperator al pacien\u0163ilor) \u0219i de cele mai multe ori testare genetic\u0103.<br \/>\nTratamentul se adreseaz\u0103 pacien\u0163ilor simptomatici. Tratamentul medicamentos poate fi eficient \u00een majoritatea cazurilor, \u00eens\u0103 \u00een cele rezistente la tratamentul medicamentos se recurge la tratament invaziv. Conform ghidurilor, at\u00e2t americane c\u00e2t \u0219i europene, terapia invaziv\u0103\u00a0 recomandat\u0103 este cea chirugical\u0103. \u00a0Conform acelora\u0219i ghiduri, datorit\u0103 rezultatelor superioare, ea trebuie efectuat\u0103 numai \u00een centre cu experien\u021b\u0103.<br \/>\nBeneficiile pacien\u0163ilor care apeleaz\u0103 la tratamentul chirurgical sunt dispari\u0163ia simptomatologiei \u0219i sc\u0103derea important\u0103 a riscului de moarte subit\u0103, pacientul revenind la o via\u0163\u0103 normal\u0103.<\/p>\n<p><strong>Cardiomyopathy Center, singurul centru specializat din Rom\u00e2nia<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/gallery.mailchimp.com\/f77d55688330df2da57a83c26\/images\/0b46c3ba-f193-499c-bbed-4c882033bea1.jpg\" width=\"180\" height=\"128\" align=\"left\" \/>\u00cen Rom\u00e2nia, singurul centru specializat este Cardiomyopathy Center din Spitalul Monza. Este un centru de avangard\u0103 \u0219i face parte din cele 5 din Europa dedicate tratamentului chirurgical al acestei boli. Cardiomyopathy Center pune la dispozi\u021bia pacien\u021bilor speciali\u0219ti dedica\u0163i, care fac posibil\u0103 efectuarea tuturor examenelor clinice \u0219i paraclinice necesare diagnosticului, dar \u0219i a analizei genetice, extrem de important\u0103 \u00een cazurile cu transmitere familial\u0103.<br \/>\nCardiomyopathy Center este afiliat centrului din Italia, din cadrul \u201cPoliclinico di Monza\u201d, cele dou\u0103 centre av\u00e2nd \u00eempreun\u0103 o experien\u021b\u0103 de peste 500 de cazuri operate<strong>.<\/strong> Centrul din Bucure\u0219ti este coordonat de c\u0103tre Dr. Lucian Doroban\u0163u \u0219i benficiaz\u0103 de expertiza Prof. Dr. Paolo Ferrazzi \u00een tratamentul chirurgical al cardiomiopatiei hipertrofice obstructive.<br \/>\nEchipa chirurgical\u0103 a centrului abordeaz\u0103 o tehnic\u0103 operatorie original\u0103, propus\u0103 de c\u0103tre Prof. P. Ferrazzi \u0219i recunoscut\u0103 la nivel interna\u021bional, fiind publicat\u0103 \u00een literatura de specialitate \u00een anul 2015, care spre deosebire de abordarea clasic\u0103 aduce beneficiul prezerv\u0103rii valvei mitrale, cu o rat\u0103 de succes de peste 99% (cea mai ridicat\u0103 rat\u0103 de prezervare a valvei mitrale din lume).<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Cardiomiopatia hipertrofic\u0103 a fost cauza unic\u0103 cea mai frecvent\u0103 de moarte subit\u0103, ap\u0103r\u00e2nd la 36% din atle\u021bii care au avut o boal\u0103 cardiac\u0103 confirmat\u0103 prin autopsie. Aceste date apar \u00een [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":4650,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[67,107],"tags":[],"class_list":["post-4649","post","type-post","status-publish","format-standard","has-post-thumbnail","category-articole","category-cardiologie"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cardiomiopatia hipertrofic\u0103 una dintre principalele cauze de deces subit la sportivii de performan\u021b\u0103 - Jurmed - Pacienti<\/title>\n<meta name=\"description\" content=\"Cardiomiopatia hipertrofic\u0103 a fost cauza unic\u0103 cea mai frecvent\u0103 de moarte subit\u0103, ap\u0103r\u00e2nd la 36% din atle\u021bii care au avut o boal\u0103 cardiac\u0103 confirmat\u0103 prin autopsie. Aceste date apar \u00een \u201dRegistrul Na\u021bional al Mor\u021bii Subite la Atle\u021bi\u201d din Statele Unite ale Americii, publicat \u00een 2016, care a studiat 2.406 mor\u021bi subite, \u00eenregistrate \u00eentre anii 1980-2011, la tinerii atle\u021bi cu v\u00e2rste \u00eentre 19\u00b16 ani. Din cele 2.406 de cazuri de moarte subit\u0103, doar 842 au avut drept cauz\u0103 de deces o boal\u0103 cardiovascular\u0103 confirmat\u0103 prin autopsie, restul prezent\u00e2nd alte cauze ale mor\u021bii.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jurmed.ro\/pacienti\/cmho\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiomiopatia hipertrofic\u0103 una dintre principalele cauze de deces subit la sportivii de performan\u021b\u0103 - Jurmed - Pacienti\" \/>\n<meta property=\"og:description\" content=\"Cardiomiopatia hipertrofic\u0103 a fost cauza unic\u0103 cea mai frecvent\u0103 de moarte subit\u0103, ap\u0103r\u00e2nd la 36% din atle\u021bii care au avut o boal\u0103 cardiac\u0103 confirmat\u0103 prin autopsie. Aceste date apar \u00een \u201dRegistrul Na\u021bional al Mor\u021bii Subite la Atle\u021bi\u201d din Statele Unite ale Americii, publicat \u00een 2016, care a studiat 2.406 mor\u021bi subite, \u00eenregistrate \u00eentre anii 1980-2011, la tinerii atle\u021bi cu v\u00e2rste \u00eentre 19\u00b16 ani. Din cele 2.406 de cazuri de moarte subit\u0103, doar 842 au avut drept cauz\u0103 de deces o boal\u0103 cardiovascular\u0103 confirmat\u0103 prin autopsie, restul prezent\u00e2nd alte cauze ale mor\u021bii.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jurmed.ro\/pacienti\/cmho\/\" \/>\n<meta property=\"og:site_name\" content=\"Jurmed - Pacienti\" \/>\n<meta property=\"article:published_time\" content=\"2016-06-21T08:08:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-06-21T08:09:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2016\/06\/Cardiomiopatia-hipertrofic\u0103.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ralucab\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"ralucab\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/cmho\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/cmho\/\"},\"author\":{\"name\":\"ralucab\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35\"},\"headline\":\"Cardiomiopatia hipertrofic\u0103 una dintre principalele cauze de deces subit la sportivii de performan\u021b\u0103\",\"datePublished\":\"2016-06-21T08:08:32+00:00\",\"dateModified\":\"2016-06-21T08:09:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/cmho\/\"},\"wordCount\":603,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/cmho\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2016\/06\/Cardiomiopatia-hipertrofic\u0103.jpg\",\"articleSection\":[\"Articole\",\"Cardiologie\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/jurmed.ro\/pacienti\/cmho\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/cmho\/\",\"url\":\"https:\/\/jurmed.ro\/pacienti\/cmho\/\",\"name\":\"Cardiomiopatia hipertrofic\u0103 una dintre principalele cauze de deces subit la sportivii de performan\u021b\u0103 - Jurmed - Pacienti\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/cmho\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/cmho\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2016\/06\/Cardiomiopatia-hipertrofic\u0103.jpg\",\"datePublished\":\"2016-06-21T08:08:32+00:00\",\"dateModified\":\"2016-06-21T08:09:06+00:00\",\"author\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35\"},\"description\":\"Cardiomiopatia hipertrofic\u0103 a fost cauza unic\u0103 cea mai frecvent\u0103 de moarte subit\u0103, ap\u0103r\u00e2nd la 36% din atle\u021bii care au avut o boal\u0103 cardiac\u0103 confirmat\u0103 prin autopsie. Aceste date apar \u00een \u201dRegistrul Na\u021bional al Mor\u021bii Subite la Atle\u021bi\u201d din Statele Unite ale Americii, publicat \u00een 2016, care a studiat 2.406 mor\u021bi subite, \u00eenregistrate \u00eentre anii 1980-2011, la tinerii atle\u021bi cu v\u00e2rste \u00eentre 19\u00b16 ani. Din cele 2.406 de cazuri de moarte subit\u0103, doar 842 au avut drept cauz\u0103 de deces o boal\u0103 cardiovascular\u0103 confirmat\u0103 prin autopsie, restul prezent\u00e2nd alte cauze ale mor\u021bii.\",\"breadcrumb\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/cmho\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jurmed.ro\/pacienti\/cmho\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/cmho\/#primaryimage\",\"url\":\"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2016\/06\/Cardiomiopatia-hipertrofic\u0103.jpg\",\"contentUrl\":\"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2016\/06\/Cardiomiopatia-hipertrofic\u0103.jpg\",\"width\":300,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/cmho\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/jurmed.ro\/pacienti\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardiomiopatia hipertrofic\u0103 una dintre principalele cauze de deces subit la sportivii de performan\u021b\u0103\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#website\",\"url\":\"https:\/\/jurmed.ro\/pacienti\/\",\"name\":\"Jurmed - Pacienti\",\"description\":\"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jurmed.ro\/pacienti\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35\",\"name\":\"ralucab\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g\",\"caption\":\"ralucab\"},\"url\":\"https:\/\/jurmed.ro\/pacienti\/author\/ralucabocancia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardiomiopatia hipertrofic\u0103 una dintre principalele cauze de deces subit la sportivii de performan\u021b\u0103 - Jurmed - Pacienti","description":"Cardiomiopatia hipertrofic\u0103 a fost cauza unic\u0103 cea mai frecvent\u0103 de moarte subit\u0103, ap\u0103r\u00e2nd la 36% din atle\u021bii care au avut o boal\u0103 cardiac\u0103 confirmat\u0103 prin autopsie. Aceste date apar \u00een \u201dRegistrul Na\u021bional al Mor\u021bii Subite la Atle\u021bi\u201d din Statele Unite ale Americii, publicat \u00een 2016, care a studiat 2.406 mor\u021bi subite, \u00eenregistrate \u00eentre anii 1980-2011, la tinerii atle\u021bi cu v\u00e2rste \u00eentre 19\u00b16 ani. Din cele 2.406 de cazuri de moarte subit\u0103, doar 842 au avut drept cauz\u0103 de deces o boal\u0103 cardiovascular\u0103 confirmat\u0103 prin autopsie, restul prezent\u00e2nd alte cauze ale mor\u021bii.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jurmed.ro\/pacienti\/cmho\/","og_locale":"ro_RO","og_type":"article","og_title":"Cardiomiopatia hipertrofic\u0103 una dintre principalele cauze de deces subit la sportivii de performan\u021b\u0103 - Jurmed - Pacienti","og_description":"Cardiomiopatia hipertrofic\u0103 a fost cauza unic\u0103 cea mai frecvent\u0103 de moarte subit\u0103, ap\u0103r\u00e2nd la 36% din atle\u021bii care au avut o boal\u0103 cardiac\u0103 confirmat\u0103 prin autopsie. Aceste date apar \u00een \u201dRegistrul Na\u021bional al Mor\u021bii Subite la Atle\u021bi\u201d din Statele Unite ale Americii, publicat \u00een 2016, care a studiat 2.406 mor\u021bi subite, \u00eenregistrate \u00eentre anii 1980-2011, la tinerii atle\u021bi cu v\u00e2rste \u00eentre 19\u00b16 ani. Din cele 2.406 de cazuri de moarte subit\u0103, doar 842 au avut drept cauz\u0103 de deces o boal\u0103 cardiovascular\u0103 confirmat\u0103 prin autopsie, restul prezent\u00e2nd alte cauze ale mor\u021bii.","og_url":"https:\/\/jurmed.ro\/pacienti\/cmho\/","og_site_name":"Jurmed - Pacienti","article_published_time":"2016-06-21T08:08:32+00:00","article_modified_time":"2016-06-21T08:09:06+00:00","og_image":[{"width":300,"height":250,"url":"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2016\/06\/Cardiomiopatia-hipertrofic\u0103.jpg","type":"image\/jpeg"}],"author":"ralucab","twitter_misc":{"Scris de":"ralucab","Timp estimat pentru citire":"3 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jurmed.ro\/pacienti\/cmho\/#article","isPartOf":{"@id":"https:\/\/jurmed.ro\/pacienti\/cmho\/"},"author":{"name":"ralucab","@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35"},"headline":"Cardiomiopatia hipertrofic\u0103 una dintre principalele cauze de deces subit la sportivii de performan\u021b\u0103","datePublished":"2016-06-21T08:08:32+00:00","dateModified":"2016-06-21T08:09:06+00:00","mainEntityOfPage":{"@id":"https:\/\/jurmed.ro\/pacienti\/cmho\/"},"wordCount":603,"commentCount":0,"image":{"@id":"https:\/\/jurmed.ro\/pacienti\/cmho\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2016\/06\/Cardiomiopatia-hipertrofic\u0103.jpg","articleSection":["Articole","Cardiologie"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jurmed.ro\/pacienti\/cmho\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jurmed.ro\/pacienti\/cmho\/","url":"https:\/\/jurmed.ro\/pacienti\/cmho\/","name":"Cardiomiopatia hipertrofic\u0103 una dintre principalele cauze de deces subit la sportivii de performan\u021b\u0103 - Jurmed - Pacienti","isPartOf":{"@id":"https:\/\/jurmed.ro\/pacienti\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jurmed.ro\/pacienti\/cmho\/#primaryimage"},"image":{"@id":"https:\/\/jurmed.ro\/pacienti\/cmho\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2016\/06\/Cardiomiopatia-hipertrofic\u0103.jpg","datePublished":"2016-06-21T08:08:32+00:00","dateModified":"2016-06-21T08:09:06+00:00","author":{"@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35"},"description":"Cardiomiopatia hipertrofic\u0103 a fost cauza unic\u0103 cea mai frecvent\u0103 de moarte subit\u0103, ap\u0103r\u00e2nd la 36% din atle\u021bii care au avut o boal\u0103 cardiac\u0103 confirmat\u0103 prin autopsie. Aceste date apar \u00een \u201dRegistrul Na\u021bional al Mor\u021bii Subite la Atle\u021bi\u201d din Statele Unite ale Americii, publicat \u00een 2016, care a studiat 2.406 mor\u021bi subite, \u00eenregistrate \u00eentre anii 1980-2011, la tinerii atle\u021bi cu v\u00e2rste \u00eentre 19\u00b16 ani. Din cele 2.406 de cazuri de moarte subit\u0103, doar 842 au avut drept cauz\u0103 de deces o boal\u0103 cardiovascular\u0103 confirmat\u0103 prin autopsie, restul prezent\u00e2nd alte cauze ale mor\u021bii.","breadcrumb":{"@id":"https:\/\/jurmed.ro\/pacienti\/cmho\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jurmed.ro\/pacienti\/cmho\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/pacienti\/cmho\/#primaryimage","url":"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2016\/06\/Cardiomiopatia-hipertrofic\u0103.jpg","contentUrl":"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2016\/06\/Cardiomiopatia-hipertrofic\u0103.jpg","width":300,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/jurmed.ro\/pacienti\/cmho\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jurmed.ro\/pacienti\/"},{"@type":"ListItem","position":2,"name":"Cardiomiopatia hipertrofic\u0103 una dintre principalele cauze de deces subit la sportivii de performan\u021b\u0103"}]},{"@type":"WebSite","@id":"https:\/\/jurmed.ro\/pacienti\/#website","url":"https:\/\/jurmed.ro\/pacienti\/","name":"Jurmed - Pacienti","description":"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jurmed.ro\/pacienti\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Person","@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35","name":"ralucab","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g","caption":"ralucab"},"url":"https:\/\/jurmed.ro\/pacienti\/author\/ralucabocancia\/"}]}},"_links":{"self":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts\/4649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/comments?post=4649"}],"version-history":[{"count":2,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts\/4649\/revisions"}],"predecessor-version":[{"id":4652,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts\/4649\/revisions\/4652"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/media\/4650"}],"wp:attachment":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/media?parent=4649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/categories?post=4649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/tags?post=4649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}